Advancing Clinical Trials
during COVID-19 & Beyond

Wednesday 24th June 2020
11:00 - 12:45 CET
Virtual Event

Register Now


About the Event

In the Toughest of days amid a Pandemic like this, when the only certainty is uncertainty,
World BI has decided to go online to help connect its attendees.
No flying Required!
Just Stay Home & meet with leading industry professionals through your screens.
In this Virtual event, experts will look into how the COVID-19 pandemic is disrupting clinical research in much of the world and how can we adapt to the new normal in a post COVID era.

Moderator

Speaker 3

Craig C. Lipset

Managing Partner

Clinical Innovation Partners

Panellists

Speaker 3

Rasmus Hogreffe, MSc.Med., MBA

Virtual Clinical Trial Expert


Speaker 3

Prasanna C Ganapathi

Associate Vice President - Global Clinical Sciences

Mylan

Speaker 3

Roberto Vallalta

Head of Clinical Operations

GSK

Speaker 3

Maria Kuthning

Global Clinical Operations, Faculty of Medicine, University of Duisburg-Essen
The University Duisburg-Essen, Faculty of Medicine

Speaker 3

Francis P. Crawley

Executive Director

Good Clinical Practice Alliance - Europe (GCPA)

Speaker 3

Gareth Powell

Patient Engagement Project Lead

The National Institute for Health Research (NIHR)

Speaker 3

Denise Lee

Head of Clinical Operations

Allergy Therapeutics

Speaker 3

Astrid Pañeda Rodríguez

Senior Director Clinical Operations

Abeona Therapeutics

Speaker 3

Jane Leahy

Patient Ambassador

Blood Cancer UK

Speaker 3

Tiphaine LAMBLOT

Clinical Operations Leader

EMEA


Agenda

Welcome Note

Panel 1

Managing clinical trials during COVID-19 and beyond

A comprehensive look at the current challenges for managing clinical trials and their solutions amid coronavirus pandemic Challenges:
  • Difficulty with patient recruitment.


  • Staff or patients being placed at greater risk.


  • Clinics allowing only essential or critical visits or refusing to take part in trials. Recruited patients dropping out of trials.


  • Vendors and contractors unable to meet obligations.


  • Risks of compromised data integrity.


Speaker 3

Moderator

Craig C. Lipset

Managing Partner
Clinical Innovation Partners

Panellist


Speaker 3

Prasanna C Ganapathi

Speaker 3

Gareth Powell

Speaker 3

Jane Leahy

Speaker 3

Denise Lee

Speaker 3

Francis P. Crawley

Speaker 3

Roberto Vallalta

Speaker 3

Astrid Pañeda Rodríguez

Q & A

Networking Break

Panel 2

Decentralized Clinical Trials – A new normal in the post COVID-19 era

  • Strategies to Bring a Study to the Patient


  • Tweaking the Present for a future New-Normal


Speaker 3

Moderator

Craig C. Lipset

Managing Partner
Clinical Innovation Partners

Panellist


Speaker 3

Maria Kuthning

Speaker 3

Francis P. Crawley

Speaker 3

Gareth Powell

Speaker 3

Tiphaine LAMBLOT

Q & A

End of Session

Sponsors

-->
-->

Newsletter



          

Media Partners

Participation Form